Biosimulation Market

Global Market Study on Biosimulation: North America to Dominate the Market in Terms of Revenue During the Forecast Period (2017 - 2022)

Biosimulation Market Segmented By Software, Services Product in Drug Development, Drug Discovery

  • October-2017
  • PMRREP3726
  • 170 Pages
  • Healthcare


Biosimulation is a technique in which computer programs are used for the simulation of biological processes. Biosimulation has wide reaching applications in the field of drug discovery and development of new drugs. It is a tool used for prediction and biosimulation is used to predict the future outcomes of current experiments related to discovery and development of new drugs.

The process of drug discovery and development is a costly one, and the failure of the drug molecule in the late phase of drug development translates into a huge wastage of time, money and other resources. Hence, there is a need of a predictive tool that will aid in predicting the future outcomes of drug development by simulation of the biological processes involved.

This is the most important factor driving the global biosimulation market. The other factors supporting the growth of the biosimulation market are the increasing expenditure on healthcare, development of advanced software and improved technology related to simulation.

According to the assessment of Persistence Market Research, the global biosimulation market is forecasted to reach a figure of about US$ 1,750 Mn in 2022 and is poised to exhibit a robust CAGR in the period of assessment.

Global Biosimulation Market

Find Out More about the Report Coverage


  • Certara, L.P
  • Simulations Plus, Inc..
  • Dassault Systemes SE
  • Schrodinger, Inc
  • Advanced Chemistry Development, Inc.
  • Entelos, Inc.
  • Evidera, Inc.
  • Genedata AG
  • Leadscope Inc
  • Acceryls Inc.
  • Others.

North America Market Set to Dominate the Global Biosimulation Market in Terms of Revenue

The market in North America is set to dominate the global biosimulation market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America biosimulation market is the most attractive market, growing at a robust CAGR over the forecast period.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Software Product Type Segment Slated to Touch a Value of About US$ 1,050 Mn in 2022

According to the projections of Persistence Market Research, the software product type segment is expected to reach a value of about US$ 1,050 Mn in the year 2022. This signifies a robust CAGR during the forecast period of 2017-2022.

The software product type segment is estimated to account for nearly two-thirds of the revenue share of the product segment by the end of the year 2017 and is expected to lose in market share by 2022 over 2017.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global biosimulation market through 2022, which include Certara, L.P., Simulations Plus, Inc., Dassault Systemes SE, Schrodinger, Inc., Advanced Chemistry Development, Inc., Entelos, Inc., Evidera, Inc., Genedata AG, Leadscope Inc. and Acceryls Inc.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Persistence Market Research

Explore Persistence Market Research’s expertise in promulgation of the business !

Market Taxonomy


  • Software
  • Services

End User

  • Academic and Government Research Institutes
  • Pharmaceutical and Biotech Companies
  • Contract Research Organizations
  • Regulatory Authorities
  • Other End Users


  • Drug Development
  • Drug Discovery
  • Other Applications


  • North America
  • Latin America
  • Europe
  • Japan
  • Asia Pacific excluding Japan
  • Middle East and Africa

Media Release


Malignant Mesothelioma Market

Global malignant mesothelioma market is estimated to represent close to US$ 160 mn, or more than 45% revenue share of the total market in 2017 and more than US$ 300 mn by 2025 end.

Intracranial Therapeutic Delivery Market

The global intracranial therapeutic delivery market is estimated at US$ 1.9 Bn in 2022, with a projected value CAGR of 7.9% for the next ten years, which indicates significant market growth..

Bowel Irrigation Systems Market

Global revenue from the bowel irrigation systems market was US$ 322.9 Mn in 2021, with the global market estimated to move ahead at a value CAGR of 2.7% to reach a market valuation of US$ 432.5 Mn by the end of 2032..

Automated Liquid Handling Systems Market

Global Automated liquid handling workstation market is projected to surpass US$ 700 million in terms of value along with a healthy CAGR by the year 2026 end.

Our Clients

Our Clients